NEW YORK (GenomeWeb News) — Hologic reported after the close of the market on Wednesday a 2 percent increase in fiscal second quarter revenues despite a 2 percent decrease in sales for its Diagnostics segment.

For the three months ended March 29, the Bedford, Mass.-based company reported revenues of $625 million compared to $612.7 million in the same quarter last year but besting the average Wall Street estimate of $609 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.